These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10512933)

  • 1. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection.
    Albers GW
    Stroke; 1999 Oct; 30(10):2230-7. PubMed ID: 10512933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status.
    Schellinger PD; Fiebach JB; Hacke W
    Stroke; 2003 Feb; 34(2):575-83. PubMed ID: 12574579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
    Ringleb PA; Schellinger PD; Schranz C; Hacke W
    Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.
    Parsons MW; Christensen S; McElduff P; Levi CR; Butcher KS; De Silva DA; Ebinger M; Barber PA; Bladin C; Donnan GA; Davis SM;
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1214-25. PubMed ID: 20087363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.
    Tatlisumak T; Strbian D; Abo Ramadan U; Li F
    Curr Vasc Pharmacol; 2004 Oct; 2(4):343-55. PubMed ID: 15320814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
    Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
    Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?
    Ma L; Gao PY; Lin Y; Xue J; Wang XC; Wang YJ; Wang YL; Liao XL; Liu ML; Cui SM; Yu L; Tong SJ; Huang YL; Zhou YM
    Neurol Res; 2009 May; 31(4):355-61. PubMed ID: 19508818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT and MRI in the diagnosis of acute stroke and their role in thrombolysis.
    Röther J
    Thromb Res; 2001 Sep; 103 Suppl 1():S125-33. PubMed ID: 11567680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke.
    Neumann-Haefelin T; Wittsack HJ; Wenserski F; Siebler M; Seitz RJ; Mödder U; Freund HJ
    Stroke; 1999 Aug; 30(8):1591-7. PubMed ID: 10436106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging.
    Tong DC; Adami A; Moseley ME; Marks MP
    Arch Neurol; 2001 Apr; 58(4):587-93. PubMed ID: 11295989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in intravenous thrombolytic therapy for treatment of acute stroke.
    Albers GW
    Neurology; 2001; 57(5 Suppl 2):S77-81. PubMed ID: 11552060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients.
    Wintermark M; Reichhart M; Cuisenaire O; Maeder P; Thiran JP; Schnyder P; Bogousslavsky J; Meuli R
    Stroke; 2002 Aug; 33(8):2025-31. PubMed ID: 12154257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluid-Attenuated Inversion Recovery Vascular Hyperintensities-Diffusion-Weighted Imaging Mismatch Identifies Acute Stroke Patients Most Likely to Benefit From Recanalization.
    Legrand L; Tisserand M; Turc G; Edjlali M; Calvet D; Trystram D; Roca P; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Feb; 47(2):424-7. PubMed ID: 26732567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.